Functional substitution by TAT-utrophin in dystrophin-deficient mice

PLoS Medicine

Volumn 6, Issue 5, 2009, Pages

  Sonnemann, Kevin J ^a   Heun Johnson, Hanke ^a   Turner, Amy J ^a   Baltgalvis, Kristen A ^a   Lowe, Dawn A ^a   Ervasti, James M ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN; TRANSACTIVATOR PROTEIN; UTROPHIN;

AFFINITY CHROMATOGRAPHY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; MOUSE; MUSCLE FUNCTION; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PUERPERIUM;

ANIMALS; CREATINE KINASE; DYSTROPHIN; GENE PRODUCTS, TAT; MICE; MICE, INBRED MDX; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; MUSCULAR DYSTROPHY, DUCHENNE; RECOMBINANT FUSION PROTEINS; UTROPHIN;

EID: 66349121942     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1000083     Document Type: Article

References (29)

1. Blake DJ, Weir A, Newey SE, Davies KE (2002) Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev 82: 291-329. (Pubitemid 34654455)
2. Sampaolesi M, Blot S, D'Antona G, Granger N, Tonlorenzi R, et al. (2006) Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 444: 574-579. (Pubitemid 44864430)
3. Gregorevic P, Allen JM, Minami E, Blankinship MJ, Haraguchi M, et al. (2006) rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice. Nat Med 12: 787-789. (Pubitemid 44050067)
4. Goyenvalle A, Vulin A, Fougerousse F, Leturcq F, Kaplan JC, et al. (2004) Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping. Science 306: 1796-1799. (Pubitemid 39601401)
5. Minetti GC, Colussi C, Adami R, Serra C, Mozzetta C, et al. (2006) Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors. Nat Med 12: 1147-1150. (Pubitemid 44527349)
6. Cohn RD, van Erp C, Habashi JP, Soleimani AA, Klein EC, et al. (2007) Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states. Nat Med 13: 204-210. (Pubitemid 46245764)
7. Yasuda S, Townsend D, Michele DE, Favre EG, Day SM, et al. (2005) Dystrophic heart failure blocked by membrane sealant poloxamer. Nature 436: 1025-1029. (Pubitemid 41191686)
8. Bogdanovich S, Krag TO, Barton ER, Morris LD, Whittemore LA, et al. (2002) Functional improvement of dystrophic muscle by myostatin blockade. Nature 420: 418-421. (Pubitemid 35415652)
9. Yin H, Lu Q, Wood M (2008) Effective exon skipping and restoration of dystrophin expression by peptide nucleic acid antisense oligonucleotides in mdx mice. Mol Ther 16: 38-45.
10. Tinsley J, Deconinck N, Fisher R, Kahn D, Phelps S, et al. (1998) Expression of full-length utrophin prevents muscular dystrophy in mdx mice. Nat Med 4: 1441-1444. (Pubitemid 28553471)
11. Rybakova IN, Patel JR, Davies KE, Yurchenco PD, Ervasti JM (2002) Utrophin binds laterally along actin filaments and can couple costameric actin with the sarcolemma when overexpressed in dystrophin-deficient muscle. Mol Biol Cell 13: 1512-1521. (Pubitemid 34522635)
12. Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF (1999) In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285: 1569-1572.
13. Haase H, Dobbernack G, Tunnemann G, Karczewski P, Cardoso C, et al. (2006) Minigenes encoding N-terminal domains of human cardiac myosin light chain-1 improve heart function of transgenic rats. FASEB J 20: 865-873. (Pubitemid 44943945)
14. Rybakova IN, Ervasti JM (2005) Identification of spectrin-like repeats required for high affinity utrophin-actin interaction. J Biol Chem 280: 23018-23023. (Pubitemid 40853212)
15. Odom GL, Gregorevic P, Allen JM, Finn E, Chamberlain JS (2008) Microutrophin delivery through rAAV6 increases lifespan and improves muscle function in dystrophic dystrophin/utrophin-deficient mice. Mol Ther 16: 1539-1545.
16. Sonnemann KJ, Fitzsimons DP, Patel JR, Liu Y, Schneider MF, et al. (2006) Cytoplasmic c-actin is not required for skeletal muscle development but its absence leads to a progressive myopathy. Dev Cell 11: 387-397. (Pubitemid 44283942)
17. Rybakova IN, Humston JM, Sonnemann KJ, Ervasti JM (2006) Dystrophin and utrophin bind actin filaments through distinct modes of contact. J Biol Chem 281: 9996-10001. (Pubitemid 43864532)
18. Warner LE, DelloRusso C, Crawford RW, Rybakova IN, Patel JR, et al. (2002) Expression of Dp260 in muscle tethers the actin cytoskeleton to the dystrophin-glycoprotein complex. Hum Mol Genet 11: 1095-1105.
19. Squire S, Raymackers JM, Vandebrouck C, Potter A, Tinsley J, et al. (2002) Prevention of pathology in mdx mice by expression of utrophin: analysis using an inducible transgenic expression system. Hum Mol Genet 11: 3333-3344. (Pubitemid 36054661)
20. Swamy M, Siegers GM, Minguet S, Wollscheid B, Schamel WW (2006) Blue native polyacrylamide gel electrophoresis (BN-PAGE) for the identification and analysis of multiprotein complexes. Sci STKE 2006: l4.
21. Petrof BJ, Shrager JB, Stedman HH, Kelly AM, Sweeney HL (1993) Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci U S A 90: 3710-3714. (Pubitemid 23111437)
22. Moens P, Baatsen PH, Marechal G (1993) Increased susceptibility of EDL muscles from mdx mice to damage induced by contractions with stretch. J Muscle Res Cell Motil 14: 446-451. (Pubitemid 23267492)
23. Lowe DA, Williams BO, Thomas DD, Grange RW (2006) Molecular and cellular contractile dysfunction of dystrophic muscle from young mice. Muscle Nerve 34: 92-100.
24. Cox GA, Cole NM, Matsumura K, Phelps SF, Hauschka SD, et al. (1993) Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity. Nature 364: 725-729. (Pubitemid 23969303)
25. Khurana TS, Davies KE (2003) Pharmacological strategies for muscular dystrophy. Nat Rev Drug Discov 2: 379-390. (Pubitemid 37361708)
26. Krag TO, Bogdanovich S, Jensen CJ, Fischer MD, Hansen-Schwartz J, et al. (2004) Heregulin ameliorates the dystrophic phenotype in mdx mice. Proc Natl Acad Sci U S A 101: 13856-13860. (Pubitemid 39298497)
27. Towbin JA, Hejtmancik JF, Brink P, Gelb B, Zhu XM, et al. (1993) X-linked dilated cardiomyopathy: Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation 87: 1854-1865. (Pubitemid 23165627)
28. Badorff C, Lee G-H, Lamphear BJ, Martone ME, Campbell KP, et al. (1999) Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med 5: 320-326. (Pubitemid 29124369)
29. r 58,000 dystrophin-associated protein (syntrophin). J Biol Chem 269: 2870-2876.